Bringing new hope to the 20%

Over the past several decades, survival rates for childhood cancers have risen dramatically. Today, 80 per cent of children who are diagnosed with cancer will live long, full lives. While remarkable, it’s still not enough—because it means that one in five kids won’t survive.

We know we can’t challenge this status quo without drastic changes. That’s why we’re embarking on new paths that extend beyond the traditional way of treating cancer.

We’re investing in work that’s aimed at finding novel ways to defeat the hardest-to-treat cancers, like by reprograming the body’s own immune system to fight the disease. We’re focused on helping experts propel groundbreaking research that will allow them to anticipate cancer relapses before they occur. And we’re making sure that survival doesn’t come at the cost of life-long side effects.

But we can’t do this alone. Join us.